Telomerase targeting drug demonstrates benefit in myelofibrosis treatment
Wednesday, September 2, 2015 - 21:00
in Health & Medicine
Imetelstat, a novel drug that targets telomerase, has demonstrated potential value in treating patients with myelofibrosis, according to the results of a new study.